Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hepion Pharmaceuticals, Inc.

0.2894
-0.0041-1.40%
Post-market: 0.2870-0.0024-0.83%18:08 EDT
Volume:716.61K
Turnover:202.51K
Market Cap:3.18M
PE:0.00
High:0.2960
Open:0.2820
Low:0.2704
Close:0.2935
Loading ...

Hepion Pharmaceuticals trading halted, news pending

TIPRANKS
·
18 Mar

Hepion Pharmaceuticals Announces Reverse Stock Split

THOMSON REUTERS
·
14 Mar

US Stocks Higher; Netflix Profit Beats Estimates

Benzinga
·
22 Jan

Hepion Pharmaceuticals Announces $9.0 Million Public Offering

THOMSON REUTERS
·
22 Jan

Hepion Pharmaceuticals Inc - Launches Public Offering of 27.7 Mln Shares

THOMSON REUTERS
·
22 Jan

Hepion Pharmaceuticals Announces $9.0 Million Public Offering

GlobeNewswire
·
22 Jan

BRIEF-Hepion Pharmaceuticals Announces Termination Of Merger Agreement With Pharma Two B

Reuters
·
11 Dec 2024

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement With Pharma Two B Ltd.

THOMSON REUTERS
·
11 Dec 2024

Hepion Pharmaceuticals Inc: Neither Party Will Be Required to Pay Other a Termination Fee as a Result of Mutual Decision to Terminate Agreement

THOMSON REUTERS
·
11 Dec 2024

Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.

GlobeNewswire
·
11 Dec 2024

Pharma Two B Announces Poster Presentation on P2B001 at the Annual Meeting of the Parkinson’s Disease Study Group

GlobeNewswire
·
05 Dec 2024

BRIEF-Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B

Reuters
·
02 Dec 2024

Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger With Pharma Two B

THOMSON REUTERS
·
02 Dec 2024

Hepion, Pharma Two B announce effectiveness of registration statement for merger

TIPRANKS
·
11 Nov 2024

Pharma Two B and Hepion Pharmaceuticals, Inc. Announce Effectiveness of Registration Statement Related to Proposed Merger

THOMSON REUTERS
·
11 Nov 2024